Africa (WHO region) vs Ecuador: HIV-positive TB patients on ART (antiretroviral therapy)
Africa (WHO region)
96.0%
in 2024
Ecuador
100.0%
in 2024
Africa (WHO region) rank
2nd
Ecuador rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Africa (WHO region)
- Ecuador
How they compare
Ecuador currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 4 times across 17 shared years of data; in 2007 it was Ecuador ahead.
Africa (WHO region) ranks 2nd and Ecuador ranks 1st of 11 groups.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa (WHO region) | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.0% | 100.0% | 68.0% | Ecuador |
| 2010s | 77.3% | 95.8% | 18.4% | Ecuador |
| 2020s | 93.2% | 93.8% | 0.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Africa (WHO region) or Ecuador?
- Ecuador, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Africa (WHO region) and Ecuador?
- 4.0%, with Ecuador ahead.
- How many years of comparable data are there for Africa (WHO region) and Ecuador?
- 17 years are reported by both, from 2007 to 2024.
- How do Africa (WHO region) and Ecuador rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Africa (WHO region) ranks 2nd and Ecuador ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.